Quantcast

Latest Pulmonology Stories

2014-03-13 08:28:38

Conference Call Today, March 13, 2014 at 10:00 a.m. ET WARRINGTON, Pa., March 13, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the fourth quarter ended December 31, 2013, as well as recent business updates. The Company will host a conference call today, March 13, 2014 at 10:00 AM ET. Conference call details are below. Key highlights...

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides novel and specific approach to treat different types of pulmonary hypertension (PH), a serious condition of the heart and lungs -- Only drug in Canada indicated to treat two rare types of PH - PAH and chronic thromboembolic pulmonary hypertension (CTEPH)(1,3) TORONTO, March...

2014-03-05 08:25:34

National Campaign Seeks to Educate People with Asthma on the Importance of 'Knowing Their Count' LANDOVER, Md., March 5, 2014 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory announced today the launch of a national awareness campaign - Know Your Count - aimed at raising awareness of the seriousness of asthma and educating asthma patients and caregivers about the importance of keeping track of the remaining doses in their rescue inhalers. The...

2014-03-03 23:27:59

The Use of Respiratory Therapists as case managers or physician extenders will improve health outcomes, reduce costs and help organizations to demonstrate meaningful use for patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). SAN DIEGO, CA (PRWEB) March 03, 2014 Respiratory Patient Centered Care is designed to meet the complex needs of patients that are diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Respiratory Therapists (RTs) are key to the success of...

2014-03-01 12:20:30

For U.S. Media Only RIDGEFIELD, Conn., March 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented data from Phase 3 studies of tiotropium delivered via the Respimat(®) inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting in San Diego. Tiotropium is being studied to determine its efficacy and safety in treating asthma patients and is not currently approved for this indication. The first results...

2014-02-27 23:02:22

Dr. Burton Feinerman was first to admit African Americans into private Florida hospital in the 1950s. Tampa, FL (PRWEB) February 27, 2014 As Black History Month comes to an end, Lung Institute’s Medical Director, Dr. Burton Feinerman, reflects on how he is still influencing change in medicine today. Practicing medicine for over half a century, Dr. Feinerman has distinguished himself as a world-renowned physician in the field of regenerative medicine with the development of innovative...

2014-02-27 16:29:07

Bronchial Thermoplasty is the first non-drug, FDA approved therapy for severe asthma CHICAGO, Feb. 27, 2014 /PRNewswire-USNewswire/ -- Like millions of people, Jeannine Childs suffers from asthma. But unlike most, her asthma was debilitating. For years she struggled with wheezing, shortness of breath and fits of coughing so severe that they often landed her in the hospital. Nothing was really working - not lifestyle changes, not medications. "It was awful, I'd have these episodes and I'd have...

2014-02-19 16:25:14

VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization. On Feb. 25, FDA's Nonprescription Drugs Advisory Committee and Pulmonary Allergy Drugs Committee will host a joint meeting to consider a new...

2014-02-18 23:30:33

This unique program will bring together key stakeholders who have a shared goal of improving the treatment and management of patient’s with Chronic Obstructive Pulmonary Disease (COPD). San Diego, CA (PRWEB) February 18, 2014 The Pulmonary Horizons (PH) Conference will be held at the DoubleTree Golf Resort in San Diego, Saturday, August 16, 2014 to Sunday, August 17, 2014. This unique program will bring together key stakeholders who have a shared goal of improving the treatment and...

2014-02-10 08:27:53

Study Aims To Evaluate Improvement in Lung Function after Treatment with NOxCureCF REHOVOT, Israel, February 10, 2014 /PRNewswire/ -- Advanced Inhalation Therapies (AIT Ltd.), a drug development company, announced today it added Schneider Children's Medical Center of Israel as the second site in its multicenter, open-label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis (CF). Schneider Children's is the largest children's...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related